Renin-Angiotensin System and Atherothrombotic Disease
- 26 May 2003
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 163 (10), 1155-1164
- https://doi.org/10.1001/archinte.163.10.1155
Abstract
The renin-angiotensin system plays a central role in the pathogenesis of cardiovascular disease. At the molecular and cellular levels, angiotensin II, the main effector peptide of the system, stimulates key components of atherosclerosis. Trials in animals and humans indicate that blocking renin-angiotensin system pathways decreases atherosclerotic plaque progression and ischemic events. This review provides a broad overview of the entire role of the renin-angiotensin system in atherothrombotic disease, ranging from molecular pathways to human genetics to the latest clinical trials.Keywords
This publication has 64 references indexed in Scilit:
- Renin-Angiotensin System and Renal Damage: Emerging Data on Angiotensin II as a Proinflammatory MediatorPublished by S. Karger AG ,2001
- G Protein β3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placementAtherosclerosis, 2000
- Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidasesCardiovascular Research, 1999
- Anti‐atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high‐cholesterol dietBritish Journal of Pharmacology, 1999
- Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Enhanced Predictability of Myocardial Infarction in Japanese by Combined Genotype AnalysisHypertension, 1995
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990